High-dimensional propensity score adjustment in studies of treatment effects using health care claims data.

Untitled work

(2001) · RePEc: Research Papers in Economics · Cited by 27,577

Revisiting the Behavioral Model and Access to Medical Care: Does it Matter?

Andersen, R. M. (1995) · Journal of Health and Social Behavior · doi:10.2307/2137284 · Cited by 9,831

Variable Selection for Propensity Score Models

Brookhart, M. A., Schneeweiss, S., Rothman, K. J., Glynn, R. J., Avorn, J., & Stürmer, T. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj149 · Cited by 2,336

Evaluating medication effects outside of clinical trials: new-user designs

Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646

A review of uses of health care utilization databases for epidemiologic research on therapeutics

Schneeweiß, S., & Avorn, J. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.10.012 · Cited by 1,290

Estimation of Causal Effects using Propensity Score Weighting: An Application to Data on Right Heart Catheterization

Hirano, K., & Imbens, G. W. (2001) · Health Services and Outcomes Research Methodology · doi:10.1023/a:1020371312283 · Cited by 1,039

Unified Methods for Censored Longitudinal Data and Causality

van der Laan, M. J., & Robins, J. M. (2003) · Springer series in statistics · doi:10.1007/978-0-387-21700-0 · Cited by 979

Quantifying Biases in Causal Models: Classical Confounding vs Collider-Stratification Bias

Greenland, S. (2003) · Epidemiology · doi:10.1097/01.ede.0000042804.12056.6c · Cited by 810

A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods

Stürmer‎, T., Joshi, M., Glynn, R. J., Avorn, J., Rothman, K. J., & Schneeweiß, S. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.07.004 · Cited by 668

Relationship Between Selective Cyclooxygenase-2 Inhibitors and Acute Myocardial Infarction in Older Adults

Solomon, D. H., Schneeweiß, S., Glynn, R. J., Kiyota, Y., Levin, R., Mogun, H., & Avorn, J. (2004) · Circulation · doi:10.1161/01.cir.0000127578.21885.3e · Cited by 506

Simultaneously Dealing With Immortal Time Bias and Residual Confounding: A Case Study of a High‐Dimensional Propensity Score Approach With a Nested Case–Control Framework in Multiple Sclerosis Research

Hossain, M. B., Ng, H. S., Zhu, F., Tremlett, H. L., & Karim, M. E. (2025) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70174 · Cited by 2

Probabilistic Analysis of Balancing Scores for Causal Inference

Wijayatunga, P. (2015) · Journal of Mathematics Research · doi:10.5539/jmr.v7n2p90 · Cited by 2

Revisión sistemática de literatura teórica sobre métodos de evaluación de impacto para evaluar políticas públicas

Vildoso, C. R. (2021) · Illustro · doi:10.36901/illustro.v11i.1298 · Cited by 2

Risk of COPD Exacerbations Associated with Statins versus Fibrates: A New User, Active Comparison, and High-Dimensional Propensity Score Matched Cohort Study

Sun, S.-H., Chang, C., Zhan, Z.-W., Chang, W.-H., Chen, Y., & Dong, Y. (2021) · International Journal of COPD · doi:10.2147/copd.s323391 · Cited by 2

Telehealth Collaborative Care Led by Clinical Pharmacists for People With Psychosis or Bipolar Disorder

Iturralde, E., Fazzolari, L., Slama, N. E., Alexeeff, S., Sterling, S., Awsare, S. V., Koshy, M. T., & Shia, M. (2024) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.23m14917 · Cited by 2

The comparative effectiveness and safety of fluticasone-salmeterol via metered-dose versus dry powder inhalers for COPD: A new user cohort study

Demkowicz, B. J., Rader, K., Wang, S. V., Kesselheim, A. S., & Feldman, W. B. (2025) · PLoS Medicine · doi:10.1371/journal.pmed.1004596 · Cited by 2

Comparative Health-Care Cost Advantage of Ipratropium over Tiotropium in COPD Patients

Dormuth, C. R., Yamaguchi, J., Wilmer, B., Hosick, D., Stürmer‎, T., & Carney, G. (2012) · Value in Health · doi:10.1016/j.jval.2011.10.014 · Cited by 2

Is thiazolidinediones use a factor in delaying the need for insulin therapy in type 2 patients with diabetes? A population-based cohort study

Carney, G., Bassett, K. L., Wright, J. M., & Dormuth, C. R. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001910 · Cited by 2

Combining Heterogeneous Databases to Detect Adverse Drug Reactions

Li, Y. (2015) · AMIA · doi:10.7916/d8z60nd1 · Cited by 2

P‐values and decision‐making: discussion of ‘Limitations of empirical calibration of p‐values using observational data’

Franklin, J. M. (2016) · Statistics in Medicine · doi:10.1002/sim.6984 · Cited by 2

Association of Hospitalization With First-Line Antidepressant Polypharmacy Among Veterans of Iraq and Afghanistan With Post-Traumatic Stress Disorder: Examining the Influence of Methodological Approaches

Stock, E. M., Copeland, L. A., Tsan, J. Y., Zeber, J. E., Veronin, M. A., & Thompson, A. W. (2016) · Military Medicine · doi:10.7205/milmed-d-15-00327 · Cited by 2

A Robustness Index of Propensity Score Estimation to Uncontrolled Confounders

Pan, W., & Bai, H. (2016) · ICSA book series in statistics · doi:10.1007/978-3-319-41259-7_4 · Cited by 2

Medicaid and Medicare

Enders, D., Schink, T., & Stürmer‎, T. (2021) · Springer series on epidemiology and public health · doi:10.1007/978-3-030-51455-6_19 · Cited by 2

Improving In-Hospital Care For Older Adults: A Mixed Methods Study Protocol to Evaluate a System-Wide Sub-Acute Care Intervention in Canada

Doupe, M. B., Enns, J. E., Kreindler, S. A., Brunkert, T., Chateau, D. G., Beaudin, P. G., Halas, G., Katz, A., & Stewart, T. L. (2022) · International Journal of Integrated Care · doi:10.5334/ijic.5953 · Cited by 2

Patient Factors Associated With Gastroesophageal Reflux Disease Diagnostic Evaluation Strategies: A Retrospective Cohort Study Using Real-World Evidence From a Large U.S. Medical Claims Database

Vajravelu, R. K., Kolb, J. M., Gellad, W. F., Scott, F. I., Tavakkoli, A., Singal, A. G., Katzka, D. A., Falk, G. W., & Wani, S. B. (2022) · Gastro Hep Advances · doi:10.1016/j.gastha.2022.03.001 · Cited by 2

Surgical Complication Risk Factor Identification Using High-Dimensional Hospital Data: An Illustrative Example in Hemostasis-Related Complications

Johnston, S. S., Jha, A., Roy, S., & Pollack, E. (2022) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s380004 · Cited by 2

Broad-Spectrum Antibiotic Use and Disease Progression in Early-Stage Melanoma Patients: A Retrospective Cohort Study

Acharya, M., Kim, T., & Li, C. (2021) · Cancers · doi:10.3390/cancers13174367 · Cited by 2

Approaches to Assessing the Quality of Observational Studies of Clinical Practice Based on the Big Data Analysis

Gilyarevsky, S. R. (2021) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2021-08-01 · Cited by 2

Examples of Existing Automated Databases

chapter:, T. F. I. C. T. W. S. O. T., Toh, S., Andrade, S. E., Raebel, M. A., Boudreau, D. M., Davis, R. L., Haffenreffer, K., Pawloski, P. A., Platt, R. G., Hennessy, S., et al. (2013) · Wiley eBooks · doi:10.1002/9781118344828.ch09 · Cited by 2

Expanding the Dimensions of Effectiveness Research in Sepsis

Walkey, A. J. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201409-1710ed · Cited by 2

Interpretable Almost Matching Exactly for Causal InferencePreprint

Liu, Y., Dieng, A., Roy, S., Rudin, C. D., & Volfovsky, A. (2018) · arXiv (Cornell University) · doi:10.48550/arxiv.1806.06802 · Cited by 3

Comparative Effectiveness Research

Setoguchi, S., & Wong, I. C. K. (2019) · Pharmacoepidemiology · doi:10.1002/9781119413431.ch26 · Cited by 2

Association Between Specificity of Sulfonylureas to Cardiac Mitochondrial KATP Channels and the Risk of Major Adverse Cardiovascular Events in Type 2 Diabetes

Wang, M., Huang, Y., Lai, J., Lee, C., Wang, P.-C., Pan, H.-Y., Lin, C., Liou, J., & Hsu, Y. (2022) · doi:10.2337/figshare.19209426 · Cited by 2

Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes

Albogami, Y., Cusi, K. J., Daniels, M. J., Wei, Y. J., & Winterstein, A. G. (2021) · doi:10.2337/figshare.14138138.v1 · Cited by 2

Data Integration through outcome adaptive LASSO and a collaborative propensity score approachPreprint

Bahamyirou, A., & Schnitzer, M. E. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2103.15218 · Cited by 2

Incidence of pancreatic cancer in angiotensin-converting enzyme inhibitors (ACEIs) versus angiotensin receptor blockers (ARBs): a population-based cohort studyPreprint

Tse, G., Zhou, J., Lee, S., Hung, J. K. F., Leung, K. S. K., Liu, Y., Zhang, Y., Liu, T., Wong, W. T., Wong, I. C. K., et al. (2022) · medRxiv · doi:10.1101/2022.07.26.22278092 · Cited by 2

Pharmacoepidemiology

Garbe, E., Suissa, S., & Douros, A. (2022) · Springer eBooks · doi:10.1007/978-1-4614-6625-3_31-1 · Cited by 2

Testing an informatics consulting service for systematic bias using negative control reference setsPreprint

Jackson, M., Gombar, S., Manickam, R., Brown, R., Tekumalla, R., Ballentine, P., & Low, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-3694681/v1 · Cited by 2

MRMCsamplesize: Sample Size Estimations for Planning Multi-Reader Multi-Case (MRMC) Studies Without Pilot Data

Robert, D. (2023) · doi:10.32614/cran.package.mrmcsamplesize · Cited by 2

Is standard radical surgery necessary for elderly patients with early-stage epithelial ovarian carcinoma? ~Propensity score matched analysis~

Kajiyama, H., Yoshihara, M., Tamauchi, S., Yoshikawa, N., Niimi, K., Suzuki, S., Shibata, K., & Kikkawa, F. (2019) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyz194 · Cited by 1

Channeling of New Neuropsychiatric Drugs—Impact on Safety and Effectiveness Studies

Abraham, D. S., Nguyen, T. P. P., Blank, L. J., Thibault, D. P., Gray, S. L., Hennessy, S., Leonard, C. E., Weintraub, D. A., & Willis, A. W. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01344-w · Cited by 1

Active surveillance pharmacovigilance for Clostridioides difficile infection and gastrointestinal bleeding: an analytic framework based on case-control studies

Vajravelu, R. K., Byerly, A. R., Feldman, R., Rothenberger, S. D., Schoen, R. E., Gellad, W. F., & Lewis, J. D. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105130 · Cited by 1

Application of High-Dimensional Propensity Score Methods to the National Health and Aging Trends Study

Hamedani, A. G., Nguyen, T. P. P., Willis, A. W., & Tazare, J. (2024) · The Journals of Gerontology Series A · doi:10.1093/gerona/glae178 · Cited by 1

Exposure to antibiotics and risk of latent autoimmune diabetes in adults and type 2 diabetes: results from a Swedish case–control study (ESTRID) and the Norwegian HUNT study

Edstorp, J., Rossides, M., Ahlqvist, E., Alfredsson, L. S., Askling, J., Giuseppe, D. D., Grill, V., Sørgjerd, E. P., Tuomi, T., Åsvold, B. O., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06302-5 · Cited by 1

Development and validation of a distributed representation model of Japanese high-dimensional administrative claims data for clinical epidemiology studies

Matsui, H., Fushimi, K., & Yasunaga, H. (2025) · BMC Medical Research Methodology · doi:10.1186/s12874-025-02549-7 · Cited by 1

Clinical Outcomes of Switching From Warfarin to Apixaban or Rivaroxaban in Patients With Atrial Fibrillation: A Nationwide Multidatabase Study

Kim, D. H., Ko, D., Singer, D. E., Cervone, A., Zhang, Y., Chen, Q., & Lin, K. J. (2025) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.124.011890 · Cited by 1

Dimensionality Reduction Techniques for Improving Propensity Score Specification: An Application to a Cohort Study Using Claims Data

Venkatesan, S., Nåtman, J., Lesén, E., Franzén, S., Shahsavari, S., Carty, L., & Ouwens, M. (2025) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70258 · Cited by 1

Prior GLP‐1 agonist use is not associated with adverse inpatient critical care outcomes: A propensity‐matched analysis

Park, A. K., Hom, J., Lorenzo, J., Rao, V. K., Hui, G., Vickers, M., & Ahuja, N. K. (2025) · Journal of Hospital Medicine · doi:10.1002/jhm.70228 · Cited by 1

Injury preceding the classical recognition of multiple sclerosis: A population-based study

Yusuf, F. L. A., Karim, M. E., Sutherland, J. M., Zhu, F., Zhao, Y., Marrie, R. A., & Tremlett, H. L. (2025) · Annals of Epidemiology · doi:10.1016/j.annepidem.2025.11.008 · Cited by 1

Scalable confounding adjustment in real-world evidence: benchmarking data-adaptive and investigator-specified strategies in a large-scale trial emulation study

Weckstein, A. R., Wang, S. V., Wyss, R., & Schneeweiß, S. (2025) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocaf204 · Cited by 1

Safety outcomes of trazodone versus antipsychotics for delirium after hospital admission in adults aged 65 years and older: a nationwide cohort study using a target trial emulation framework

Yang, C., Wilkins, J. M., Pritchard, K. T., Chen, Q., Liu, X., Kim, D. H., & Lin, K. J. (2025) · The Lancet Healthy Longevity · doi:10.1016/j.lanhl.2025.100804 · Cited by 1

Comprehensive drug safety assessment of sodium-glucose co-transporter 2 inhibitors, glucagon-like peptide 1 receptor agonists, and dipeptidyl peptidase 4 inhibitors: A Danish population-based active comparator new user cohort study

Lund, L. C., Simonsen, E., & Pottegård, A. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113341 · Cited by 1

Automated generation of comparator patients in the electronic medical record

Rigdon, J., Ostasiewski, B., Woelfel, K., Wiseman, K., Hetherington, T. C., Downs, S., & Kowalkowski, M. (2023) · Learning Health Systems · doi:10.1002/lrh2.10362 · Cited by 1

Safety Comparison of Risk of Liver Dysfunction between Generic and Brand Statin Drugs Marketed in Japan: A Cohort Study Using MID-NET®

Maruyama, H., Kinoshita, Y., Ando, T., Okui, J., Komamine, M., Kajiyama, K., Horiuchi, N., & Uyama, Y. (2025) · Therapeutic Innovation & Regulatory Science · doi:10.1007/s43441-025-00904-w · Cited by 1

Durability of sotatercept response in pulmonary hypertension: Insights from extended real-world follow-up

Naeem, A., Bolaji, O., Kidess, G. G., Fahed, J., Jahan, S., Basit, J., Khan, M. H., Mangeshkar, S., Sorci, S., Kassis‐George, H., et al. (2026) · International Journal of Cardiology · doi:10.1016/j.ijcard.2025.134150 · Cited by 1

Statin use is associated with lower rates of stricture development in patients with Crohn’s disease: a propensity score-matched study of two nationwide population databases

Verma, A., Kulkarni, C. V., Pike, C. W., Gombar, S., Dasarathy, D., Rieder, F., & Sinha, S. R. (2026) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjag034 · Cited by 1

Semaglutide use linked to lower COVID-19 and influenza severity with better renal outcomes after pandemic or seasonal infection

Matson, R. P., Venkatakrishnan, A., Murugadoss, K., & Soundararajan, V. (2026) · Biology Methods and Protocols · doi:10.1093/biomethods/bpag042 · Cited by 1

Comparative effectiveness of azithromycin versus roflumilast in patients with chronic obstructive pulmonary disease: emulated target trial

Portela, G., Wang, S. V., Suissa, S., Schneeweiß, S., & Feldman, W. B. (2026) · BMJ · doi:10.1136/bmj-2026-100111 · Cited by 1

Measuring the performance of an integrative patient similarity measure in the context of adverse drug events

Keshava, N. (2017) · IEEE-EMBS International Conference on Biomedical and Health Informatics (BHI ...) · doi:10.1109/bhi.2017.7897213 · Cited by 1

Almost-Exact Matching with Replacement for Causal Inference

Dieng, A., Liu, Y., Roy, S., Rudin, C. D., & Volfovsky, A. (2018) · Cited by 1

High-Dimensional Propensity Score-Adjusted Case-Crossover for Discovering Adverse Drug Reactions from Computerized Administrative Healthcare Databases

Volatier, É., Salvo, F., Pariente, A., Courtois, É., Escolano, S., Tubert‐Bitter, P., & Ahmed, I. (2022) · Drug Safety · doi:10.1007/s40264-022-01148-5 · Cited by 2

Impactability Modeling for Reducing Medicare Accountable Care Organization Payments and Hospital Events in High-Need High-Cost Patients: Longitudinal Cohort Study

Smith, M. A., Yu, M., Huling, J. D., Wang, X., DeLonay, A., & Jaffery, J. B. (2022) · Journal of Medical Internet Research · doi:10.2196/29420 · Cited by 1

KI basierter Rapid Evidence Generator mit risikoadjustiertem Propensity Score Matching

Zahn, T., Hesse, E., Herrera-Rodriguez, A., Walker, J., & Enders, D. (2023) · Prävention und Gesundheitsförderung · doi:10.1007/s11553-023-01048-1 · Cited by 1

A simple Cox approach to estimating risk ratios without sharing individual-level data in multisite studies

Shu, D., Zou, G., Hou, L., Petrone, A. B., Maro, J. C., FIREMAN, B. H., Toh, S., & Connolly, J. G. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae188 · Cited by 1

Real-World Effectiveness of Bebtelovimab Versus Nirmatrelvir/Ritonavir in Outpatients with COVID-19

Rowan, C. G., Nichols, R., Dhopeshwarkar, N., Alyea, J. M., Zhu, B., Toh, S., Chan, K. A., & Grace, E. L. (2024) · Pulmonary Therapy · doi:10.1007/s41030-024-00284-w · Cited by 1

Cardiovascular risk associated with glucagon-like peptide-1 receptor agonists versus other conventional glucose-lowering drugs in patients with type-2 diabetes: protocol for a nationwide observational comparative study in routine care

Danchin, N., Lemesle, G., Mazighi, M., Mohammedi, K., Schiele, F., Sibon, I., Caron, A., Emery, C., Nevoret, C., Vigié, L., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-087790 · Cited by 1

Finding the Optimal Number of Splits and Repetitions in Double Cross‐Fitting Targeted Maximum Likelihood Estimators

Karim, M. E., & Mondol, M. H. (2025) · Pharmaceutical Statistics · doi:10.1002/pst.70022 · Cited by 1

Using Exploratory Visualization in the Analysis of Medical Product Safety in Observational Healthcare Data

Ryan, P. B. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5329-1_21 · Cited by 1

The ACCE method: an approach for obtaining quantitative or qualitative estimates of residual confounding

Smith, E. G. (2014) · F1000Research · doi:10.12688/f1000research.4801.1 · Cited by 1

Introduction to Causal Inference Approaches

Stuart, E. A., & Naeger, S. (2017) · Health services research · doi:10.1007/978-1-4939-6704-9_8-1 · Cited by 1

Effects of longer use of recombinant human soluble thrombomodulin on outcomes of patients with disseminated intravascular coagulation based on a national administrative database

Murata, A., & Matsuda, S. (2014) · Asian Pacific Journal of Disease Management · doi:10.7223/apjdm.8.17 · Cited by 1

Adherence to recommendations and clinical outcomes of patients hospitalized for stroke: the role of the admission ward—a real-life investigation from Italy

Rea, F., Micieli, G., Musicco, M., Cavallini, A. M., Santucci, C., Merlino, L. G., Ieva, F., Ferrarese, C., & Corrao, G. (2019) · Neurological Sciences · doi:10.1007/s10072-019-03867-7 · Cited by 1

Imputing pre-diagnosis health behaviour in cancer registry data and investigating its relationship with oesophageal cancer survival time

Fahey, P. P., Page, A., Astell‐Burt, T., & Stone, G. (2021) · PLoS ONE · doi:10.1371/journal.pone.0261416 · Cited by 1

Adverse Events After Initiating Angiotensin-Converting Enzyme Inhibitor/Angiotensin II Receptor Blocker Therapy in Individuals with Heart Failure and Multimorbidity

Tisminetzky, M. S., Gurwitz, J. H., Tabada, G. H., Reynolds, K., Fortmann, S. P., Garcia, E. A., Pham, T. H., Goldberg, R. J., & Go, A. S. (2022) · The American Journal of Medicine · doi:10.1016/j.amjmed.2022.08.010 · Cited by 1

Données et preuves en vie réelle dans l’évaluation des technologies de santé : dans quels cas sont-elles complémentaires, substitutives, ou les seules sources de données par rapport aux essais cliniques ?

de Pouvourville, G., Armoiry, X., Lavorel, A., Bilbault, P., Maugendre, P., Bensimon, L., Beziz, D., Blin, P., Borget, I., Bouée, S., et al. (2022) · Therapies · doi:10.1016/j.therap.2022.10.067 · Cited by 1

Are adverse events higher among patients with acute optic neuritis prescribed glucocorticoids? A retrospective, longitudinal cohort study

Lott, L. B. D., Brennan, B., Wallace, B. I., Kerber, K. A., Burke, J. F., Roslin, C., Terman, S. W., Andrews, C., Waljee, A. K., & Banerjee, M. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-076801 · Cited by 1

Detecting adverse drug reactions in the general practice healthcare database

Reps, J. (2014) · Nottingham ePrints (University of Nottingham) · Cited by 1

Letter by Potter and Le Lorier Regarding Article, “Cardiovascular Outcomes and Mortality in Patients Using Clopidogrel With Proton Pump Inhibitors After Percutaneous Coronary Intervention or Acute Coronary Syndrome”

Potter, B. J., & Lorier, J. L. (2010) · Circulation · doi:10.1161/circulationaha.110.939991 · Cited by 1

Biologics-associated Risks for Incident Skin and Soft Tissue Infections in Psoriasis Patients: Results from Propensity Score-Stratified Survival AnalysisPreprint

Liu, S., Hsieh, T.-H. J., Chen, L. Y., Huang, Y., & Huang, Y.-H. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/126383 · Cited by 1

Evaluating signals generated in a large-scale sequence symmetry analyses: macrolides and heart failure; and NSAIDs and pneumoniaPreprint

Sinnott, S., Lin, K., Wang, S., Hallas, J., Desai, R. J., Schneeweiß, S., & Gagne, J. (2020) · medRxiv · doi:10.1101/2020.03.19.20038596 · Cited by 1

Introduction to Causal Inference Approaches

Stuart, E. A., & Naeger, S. (2019) · Health services research · doi:10.1007/978-1-4939-8715-3_33 · Cited by 1

Response to: The use of low-dose quetiapine does not necessarily increase the risk of major adverse cardiovascular events

Højlund, M., Andersen, K., Ernst, M. T., Correll, C. U., & Hallas, J. (2023) · Acta Neuropsychiatrica · doi:10.1017/neu.2023.3 · Cited by 1

adapt4pv: Adaptive Approaches for Signal Detection in Pharmacovigilance

Ahmed, I. (2020) · doi:10.32614/cran.package.adapt4pv · Cited by 1

“Double Machine Learning for Causal Inference in High-Dimensional Electronic Health Records”Preprint

Du, M., Guo, Y., Li, X., Català, M., & Prieto‐Alhambra, D. (2025) · medRxiv · doi:10.1101/2025.07.21.25331944 · Cited by 1

Increased hospitalization for hemorrhages in patients taking amiodarone with warfarin: a population-based cohort study

Lam, J. (2011) · MacSphere (McMaster University) · doi:10.71548/11085

Association Between Early Follow-up with a Nephrologist and Death in Survivors of Acute Kidney Injury

Harel, Z. (2012) · TSpace (University of Toronto)

New Perspectives on Regression Adjustment in Causal Inference, with Applications to Educational Program Evaluation

Sales, A. (2013) · Deep Blue (University of Michigan)

Healthcare costs and resource utilization in treated versus untreated chronically infected hepatitis C patients

Kim, Y. A. (2014) · Texas ScholarWorks (Texas Digital Library)

Confounding Adjustment in Comparative Studies of Newly Marketed Medications

Kumamaru, H. (2015) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)

Response to commentary by Marcus and Gibbons

Rassen, J. A., Glynn, R. J., Rothman, K. J., Setoguchi, S., & Schneeweiß, S. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3211

Bayesian Methods and Computation for Large Observational Datasets

Watts, K. L. (2013) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)

Bias in Comparative Effectiveness Studies Due to Regional Variation in Medical Practice Intensity

Huybrechts, K. F., Seeger, J. D., Rothman, K. J., Glynn, R. J., Avorn, J., & Schneeweiß, S. (2012) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.112.966093

Statistical Methods for Effect Estimation in Biomedical Research: Robustness and Efficiency

Cefalu, M. S. (2013) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)

Reverse Engineering Measures of Clinical Care Quality: Sequential Pattern Mining

Chiu, H., & Meeker, D. (2015) · Lecture notes in computer science · doi:10.1007/978-3-319-21843-4_17

Enhancing drug safety through active surveillance of observational healthcare data

Ryan, P. B. (2019) · ProQuest Demo Repository · doi:10.17615/y9re-3w33

Retrospective Mixed Model and Propensity Score Methods for Case Control Data

Hayeck, T. J. (2015) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)

Active presecription drug safety surveillance: Exploring OMOP 2011-2012 experiments

Gruber, S., & Robins, J. M. (2013)

Using High-Dimensional Disease Risk Scores in Comparative Effectiveness Research of New Treatments

Wyss, R. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/rrw8-0d84

Data Mining in Pharmacoepidemiological Databases

Suling, M., Weber, R. J., & Pigeot, I. (2013) · Springer eBooks · doi:10.1007/978-3-642-35494-6_21

The Association of Cancer Development in Patients with Systemic Lupus Erythematosus

Coley, R. M. (2016) · ScholarWorks (Walden University)

Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on prevention of stroke: Which one is better?

Xiao, L., Ouyang, H., Su, Q., & Huang, Y. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.08.150

Evaluation of the Performance of the High-Dimensional Propensity Score Algorithm to Adjust for Confounding of Treatment Effects Estimated in Healthcare Claims Data

Le, H. V. (2012)

Commentary

Haneuse, S. (2016) · Epidemiology · doi:10.1097/ede.0000000000000566

Comparing Methods of Applying the Propensity Score to Control Selection Bias in Studies of Prostate Cancer

Fang, X., Shahinian, V. B., Sheffield, K. M., Tan, A., Jupiter, D. C., & Kuo, Y. (2016) · J of Health Science · doi:10.17265/2328-7136/2016.05.006

Questions in the comparative effectiveness of dabigatran and warfarin in atrial fibrillation

Alonso, Á., Lutsey, P. L., Chen, L. Y., MacLehose, R. F., & Bengtson, L. G. S. (2017) · Journal of Cardiology · doi:10.1016/j.jjcc.2017.02.003

Medication prescribing in the elderly and the effect on health related outcomes: an investigation of bias in observational studies using computerised claims databases.

Pratt, N. L. (2010) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)

Data Science, Design, and Causal Inference

Platt, R. W. (2017) · Current Epidemiology Reports · doi:10.1007/s40471-017-0129-5

Utilization and Safety of Antipsychotic Medications in Special Populations

Park, Y. (2017) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)

Regularization and Hierarchical Prior Distributions for Adjustment with Health Care Claims Data: Rethinking Comorbidity ScoresPreprint

Spertus, J. V., Adhikari, S., & Normand, S. T. (2017) · arXiv (Cornell University) · doi:10.48550/arxiv.1711.05243 · Cited by 1

Pediatric Adverse Event Rates Associated With Inexperience in Teaching Hospitals: A Multilevel Analysis

Dynan, L., Goudie, A., & Brady, P. W. (2017) · Journal for Healthcare Quality · doi:10.1097/jhq.0000000000000121

Evaluation of the Performance of the High-Dimensional Propensity Score Algorithm to Adjust for Confounding of Treatment Effects Estimated in Healthcare Claims Data

Le, H. V. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/9srw-nw85

Confounding adjustment via a semi‐automated high‐dimensional propensity score algorithm: an application to electronic medical records

Toh, S., Rodríguez, L. A. G., & Hernán, M. Á. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2152 · Cited by 85

High dimensional versus conventional propensity score matching investigating gastrointestinal complications in coxib users vs. nonselective NSAIDS users

Garbe, E., Kloss, S., Schill, W., Suling, M., & Schneeweiss, S. (2011) · German Medical Science (German Research Foundation) · doi:10.3205/11gmds243

Effects of aggregation of drug and diagnostic codes on the performance of the high-dimensional propensity score algorithm: an empirical example

Le, H. V., Poole, C., Brookhart, M. A., Schoenbach, V. J., Beach, K. J., Layton, J. B., & Stürmer‎, T. (2013) · BMC Medical Research Methodology · doi:10.1186/1471-2288-13-142 · Cited by 24

High-dimensional versus conventional propensity scores in a comparative effectiveness study of coxibs and reduced upper gastrointestinal complications

Garbe, E., Kloss, S., Suling, M., Pigeot, I., & Schneeweiß, S. (2012) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-012-1334-2 · Cited by 60